Ben Tre Pharmaceutical JSC (DBT) — Cash Flow Reinvestment Rate
Ben Tre Pharmaceutical JSC (DBT) has a Cash Flow Reinvestment Rate of 0.03x as of June 2020, reinvesting ₫1.27 Billion (capex ₫87.53 Million plus investments ₫-1.18 Billion) from operating cash flow of ₫37.04 Billion. Check DBT cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ben Tre Pharmaceutical JSC Cash Flow Reinvestment Rate (2016–2017)
Historical reinvestment intensity for Ben Tre Pharmaceutical JSC across 2 annual periods. See DBT free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Annual Cash Flow Reinvestment Rate for Ben Tre Pharmaceutical JSC (2016–2017)
Year-by-year capital reinvestment analysis for Ben Tre Pharmaceutical JSC. For live market cap and broader valuation context, see DBT stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (VND) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 0.80x | ₫40.69 Billion | ₫51.07 Billion | ₫9.02 Billion | ▼ -29.1% |
| 2016 | 1.12x | ₫36.73 Billion | ₫32.71 Billion | ₫4.50 Billion | — |